1. Home
  2. TEVA
  3. TEVA News

Latest Teva Pharmaceutical Industries Limited (TEVA) News on July 26, 2024

TEVA

MT Newswires

2 days ago

Sanofi, Teva Pharmaceuticals Expect Topline Results From Phase 2b Duvakitug Trial in Q4

Teva and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in Patients with Inflammatory Bowel Disease
TEVA

Business Wire

2 days ago

Teva and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in Patients with Inflammatory Bowel Disease

TEVA's Ajovy Meets Goal in Migraine Prevention Study for Kids
TEVA

Zacks

7 days ago

TEVA's Ajovy Meets Goal in Migraine Prevention Study for Kids

Teva reports positive data from Phase III paediatric migraine prevention trial
TEVA

Clinical Trials Arena

8 days ago

Teva reports positive data from Phase III paediatric migraine prevention trial

TEVA

MT Newswires

8 days ago

Teva Pharmaceutical Says Trial of Ajovy to Prevent Episodic Migraine in Children Reaches Primary Endpoint

Teva Announces First Phase 3 Evidence of Efficacy and Safety of an Anti-CGRP Monoclonal Antibody in Children in AJOVY® (fremanezumab) SPACE Trial for Prevention of Episodic Migraine
TEVA

Business Wire

8 days ago

Teva Announces First Phase 3 Evidence of Efficacy and Safety of an Anti-CGRP Monoclonal Antibody in Children in AJOVY® (fremanezumab) SPACE Trial for Prevention of Episodic Migraine

3 No-Brainer Stocks to Buy With $200 Right Now
TEVA

Motley Fool

10 days ago

3 No-Brainer Stocks to Buy With $200 Right Now

TEVA

Morningstar Research

14 days ago

Analyst Report: Teva Pharmaceutical Industries Limited

3 Generic Drug Stocks to Watch Amid Improving Market Prospects
TEVA

Zacks

16 days ago

3 Generic Drug Stocks to Watch Amid Improving Market Prospects

TEVA

Argus Research

17 days ago

Market Digest: TEVA

TEVA

Argus Research

17 days ago

Analyst Report: Teva Phar Inds Lt

TEVA

Morningstar Research

17 days ago

Analyst Report: Teva Pharmaceutical Industries Limited

Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at 8 a.m. ET on July 31, 2024
TEVA

Business Wire

24 days ago

Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at 8 a.m. ET on July 31, 2024

FTC investigates Teva over contested product patents
TEVA

Pharmaceutical Technology

24 days ago

FTC investigates Teva over contested product patents

TEVA

MT Newswires

25 days ago

Update: Market Chatter: Teva Pharmaceuticals Faces FTC Probe on Patent Listings

TEVA

MT Newswires

25 days ago

Correction: Top Midday Stories: Boeing to Acquire Spirit AeroSystems; Robinhood Acquires Pluto; FTC Probes Teva; BlackRock Acquires Preqin; SCOTUS Grants Trump Some Immunity

TEVA

MT Newswires

25 days ago

Market Chatter: FTC Opens Investigation Into Teva Pharmaceuticals

TEVA

MT Newswires

25 days ago

Vanda Pharmaceuticals Says Federal Court Allows Patent Lawsuit Over Hetlioz

New AJOVY® (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses
TEVA

Business Wire

a month ago

New AJOVY® (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses

TEVA

MT Newswires

a month ago

Jefferies Adjusts Price Target on Teva Pharmaceutical Industries to $23 From $19, Maintains Buy Rating

TEVA

MT Newswires

a month ago

Teva Pharmaceutical Pays $750 Million to Resolve Tax-Related Litigation

Teva Reaches Agreement With the Israel Tax Authority to Resolve All Pending Litigation for the Company's Taxable Years 2008-2020
TEVA

Business Wire

a month ago

Teva Reaches Agreement With the Israel Tax Authority to Resolve All Pending Litigation for the Company's Taxable Years 2008-2020

TEVA

Morningstar Research

a month ago

Analyst Report: Teva Pharmaceutical Industries Limited

TEVA

MT Newswires

a month ago

Teva Pharmaceutical Launches Generic Victoza in US

Teva Announces Launch of Authorized Generic of Victoza® (liraglutide injection 1.8mg), in the United States
TEVA

Business Wire

a month ago

Teva Announces Launch of Authorized Generic of Victoza® (liraglutide injection 1.8mg), in the United States

Here's Why You Should Consider Buying Alvotech (ALVO) Stock
TEVA

Zacks

a month ago

Here's Why You Should Consider Buying Alvotech (ALVO) Stock

Did Teva Pharmaceutical Industries Limited (TEVA)’s “Pivot to Growth” Strategy Help It Get a Positive Rating from Analysts?
TEVA

Insider Monkey

a month ago

Did Teva Pharmaceutical Industries Limited (TEVA)’s “Pivot to Growth” Strategy Help It Get a Positive Rating from Analysts?

TEVA

MT Newswires

a month ago

Teva Pharmaceutical Industries 'Well-Positioned' for Further Growth, UBS Says

TEVA

MT Newswires

a month ago

Teva Pharmaceutical Sues Corcept Therapeutics Alleging Market Monopolization for Cushing's Syndrome Drug Korlym

Teva sues Corcept over mifepristone 'monopoly' for rare disorder
TEVA

Reuters

a month ago

Teva sues Corcept over mifepristone 'monopoly' for rare disorder

TEVA

Morningstar Research

a month ago

Analyst Report: Teva Pharmaceutical Industries Limited

FDA panel votes to recommend Eli Lilly's Alzheimer's drug
TEVA

Yahoo Finance Video

2 months ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

TEVA

GlobeNewswire

2 months ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit
TEVA

Reuters

2 months ago

California seeks company profits in Big Oil climate lawsuit

TEVA

USA TODAY

2 months ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis
TEVA

GlobeNewswire

2 months ago

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock
TEVA

Business Wire

2 months ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research
TEVA

GlobeNewswire

2 months ago

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas
TEVA

Business Wire

2 months ago

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia
TEVA

Business Insider

2 months ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women
TEVA

Insider Monkey

2 months ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase
TEVA

Reuters

2 months ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

TEVA

Insider Monkey

2 months ago

Best Date Night Fragrance in 2024

France's Macron calls snap legislative elections after EU poll blow
TEVA

AFP

2 months ago

France's Macron calls snap legislative elections after EU poll blow

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events
TEVA

Investor's Business Daily

2 months ago

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events

Toronto Pearson conducts annual full-scale emergency exercise
TEVA

CNW Group

2 months ago

Toronto Pearson conducts annual full-scale emergency exercise

European Union Vote Delivers Shift to Right, in Blow to French and German Governments
TEVA

The Wall Street Journal

2 months ago

European Union Vote Delivers Shift to Right, in Blow to French and German Governments

TEVA

MT Newswires

2 months ago

Barclays Adjusts Price Target on Teva Pharmaceutical Industries to $21 From $20, Maintains Overweight Rating

Teva to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
TEVA

Business Wire

2 months ago

Teva to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

TEVA Stock Rises 135% in a Year: What's Driving the Recovery?
TEVA

Zacks

2 months ago

TEVA Stock Rises 135% in a Year: What's Driving the Recovery?

New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate)
TEVA

Business Wire

2 months ago

New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate)

Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024
TEVA

Business Wire

2 months ago

Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024

FDA approves Teva Pharmaceuticals’ AUSTEDO XR for TD and HD chorea
TEVA

Pharmaceutical Technology

2 months ago

FDA approves Teva Pharmaceuticals’ AUSTEDO XR for TD and HD chorea

TEVA

MT Newswires

2 months ago

Teva Pharmaceutical Gains FDA Approval for Daily Huntington's Disease Pill

Teva Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24–48 mg/day)
TEVA

Business Wire

2 months ago

Teva Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24–48 mg/day)

TEVA

Argus Research

2 months ago

Weekly Stock List

TEVA

Morningstar Research

2 months ago

Analyst Report: Teva Pharmaceutical Industries Limited

TEVA

Morningstar Research

2 months ago

Analyst Report: Teva Pharmaceutical Industries Limited

Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
TEVA

Business Wire

2 months ago

Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.

Insider Sale: Chief Accounting Officer Amir Weiss Sells 28,135 Shares of Teva Pharmaceutical ...
TEVA

GuruFocus.com

2 months ago

Insider Sale: Chief Accounting Officer Amir Weiss Sells 28,135 Shares of Teva Pharmaceutical ...

TEVA

MT Newswires

2 months ago

Teva Pharmaceutical Industries Insider Sold Shares Worth $470,794, According to a Recent SEC Filing

TEVA

MT Newswires

2 months ago

Teva Pharmaceutical Industries Insider Sold Shares Worth $254,807, According to a Recent SEC Filing

Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations
TEVA

Business Wire

2 months ago

Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations

Is Aldeyra Therapeutics (ALDX) Stock Outpacing Its Medical Peers This Year?
TEVA

Zacks

2 months ago

Is Aldeyra Therapeutics (ALDX) Stock Outpacing Its Medical Peers This Year?

Israel’s Once-Dominant Drugmaker Is Revived by Innovation
TEVA

The Wall Street Journal

2 months ago

Israel’s Once-Dominant Drugmaker Is Revived by Innovation

TEVA

MT Newswires

2 months ago

Piper Sandler Adjusts Price Target on Teva Pharmaceutical Industries to $20 From $19, Maintains Overweight Rating

Should Value Investors Buy Teva Pharmaceutical Industries (TEVA) Stock?
TEVA

Zacks

2 months ago

Should Value Investors Buy Teva Pharmaceutical Industries (TEVA) Stock?

TEVA Q1 Earnings Miss, Schizophrenia Study Meets Goal, Stock Up
TEVA

Zacks

3 months ago

TEVA Q1 Earnings Miss, Schizophrenia Study Meets Goal, Stock Up

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2024 Earnings Call Transcript
TEVA

Insider Monkey

3 months ago

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2024 Earnings Call Transcript

Affirm stock sinking, Good Buy or Goodbye: Market Domination
TEVA

Yahoo Finance Video

3 months ago

Affirm stock sinking, Good Buy or Goodbye: Market Domination

Teva Pharmaceutical Industries First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
TEVA

Simply Wall St.

3 months ago

Teva Pharmaceutical Industries First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Teva and Medincell report positive data for TEV-‘749 in schizophrenia trial
TEVA

Clinical Trials Arena

3 months ago

Teva and Medincell report positive data for TEV-‘749 in schizophrenia trial

TEVA

Morningstar Research

3 months ago

Analyst Report: Teva Pharmaceutical Industries Limited

Teva Pharma's Turnaround Story: How A Key Win Helped It Clinch A Five-Year High
TEVA

Investor's Business Daily

3 months ago

Teva Pharma's Turnaround Story: How A Key Win Helped It Clinch A Five-Year High

Teva Stock Powers Ahead as Schizophrenia News Offsets Mixed Earnings
TEVA

Barrons.com

3 months ago

Teva Stock Powers Ahead as Schizophrenia News Offsets Mixed Earnings

Teva Pharmaceutical Industries (TEVA) Q1 2024 Earnings Call Transcript
TEVA

Motley Fool

3 months ago

Teva Pharmaceutical Industries (TEVA) Q1 2024 Earnings Call Transcript

TEVA

MT Newswires

3 months ago

Update: Teva Pharmaceutical Shares Rise After Reporting Higher Q1 Earnings, Revenue; 2024 Guidance Reaffirmed

Teva Stock Is Powering Ahead as Schizophrenia News Offsets Mixed Earnings
TEVA

Barrons.com

3 months ago

Teva Stock Is Powering Ahead as Schizophrenia News Offsets Mixed Earnings

Teva Pharmaceutical Industries (TEVA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
TEVA

Zacks

3 months ago

Teva Pharmaceutical Industries (TEVA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

TEVA

MT Newswires

3 months ago

Sector Update: Health Care Stocks Lean Lower Pre-Bell Wednesday

TEVA

MT Newswires

3 months ago

Sector Update: Health Care

Teva Surges To 5-Year High On Maintained Outlook Despite Mixed First Quarter
TEVA

Investor's Business Daily

3 months ago

Teva Surges To 5-Year High On Maintained Outlook Despite Mixed First Quarter

TEVA

MT Newswires

3 months ago

Teva Pharmaceutical Industries Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed

TEVA

Reuters

3 months ago

REFILE-UPDATE 1-Teva Pharm Q1 profit misses estimates, revenue rises

Teva Pharm Q1 profit misses estimates, revenue rises
TEVA

Reuters

3 months ago

Teva Pharm Q1 profit misses estimates, revenue rises

TEVA

Reuters

3 months ago

Teva Pharm Q1 profit falls short of estimates, revenue gains

Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook
TEVA

Business Wire

3 months ago

Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook

Teva Earnings Are Soon. What Could Keep the Stock Gains Going.
TEVA

Barrons.com

3 months ago

Teva Earnings Are Soon. What Could Keep the Stock Gains Going.

20 States with the Highest Fertility Rates in the US
TEVA

Insider Monkey

3 months ago

20 States with the Highest Fertility Rates in the US

Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
TEVA

Zacks

3 months ago

Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?

Teva Pharmaceutical Industries (NYSE:TEVA) shareholders have earned a 54% return over the last year
TEVA

Simply Wall St.

3 months ago

Teva Pharmaceutical Industries (NYSE:TEVA) shareholders have earned a 54% return over the last year

A Week Of Fast-Moving Stocks Ahead: Disney, Toyota, Ferrari, Constellation
TEVA

Investor's Business Daily

3 months ago

A Week Of Fast-Moving Stocks Ahead: Disney, Toyota, Ferrari, Constellation

Unlocking Q1 Potential of Teva Pharmaceutical Industries (TEVA): Exploring Wall Street Estimates for Key Metrics
TEVA

Zacks

3 months ago

Unlocking Q1 Potential of Teva Pharmaceutical Industries (TEVA): Exploring Wall Street Estimates for Key Metrics

Teva to Present at the 2024 Bank of America Healthcare Conference
TEVA

Business Wire

3 months ago

Teva to Present at the 2024 Bank of America Healthcare Conference

Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2024 Earnings Call Transcript
TEVA

Insider Monkey

3 months ago

Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2024 Earnings Call Transcript

Teva’s 2023 Healthy Future Report Showcases Renewed Sustainability Strategy and Ambitious Targets
TEVA

Business Wire

3 months ago

Teva’s 2023 Healthy Future Report Showcases Renewed Sustainability Strategy and Ambitious Targets

TEVA

Thomson Reuters StreetEvents

3 months ago

Q1 2024 Corcept Therapeutics Inc Earnings Call

TEVA

GuruFocus.com

3 months ago

Corcept Therapeutics Inc (CORT) Q1 2024 Earnings Call Transcript Highlights: Strong Growth Amid ...

TEVA

MT Newswires

3 months ago

Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals

U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)
TEVA

GlobeNewswire

3 months ago

U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)

Share on Social Networks: